These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 15342404

  • 1. Enhanced redundancy in Akt and mitogen-activated protein kinase-induced survival of malignant versus normal prostate epithelial cells.
    Uzgare AR, Isaacs JT.
    Cancer Res; 2004 Sep 01; 64(17):6190-9. PubMed ID: 15342404
    [Abstract] [Full Text] [Related]

  • 2. Gonadotropin-releasing hormone induces apoptosis of prostate cancer cells: role of c-Jun NH2-terminal kinase, protein kinase B, and extracellular signal-regulated kinase pathways.
    Kraus S, Levy G, Hanoch T, Naor Z, Seger R.
    Cancer Res; 2004 Aug 15; 64(16):5736-44. PubMed ID: 15313914
    [Abstract] [Full Text] [Related]

  • 3. Tyrphostin AG825 triggers p38 mitogen-activated protein kinase-dependent apoptosis in androgen-independent prostate cancer cells C4 and C4-2.
    Murillo H, Schmidt LJ, Tindall DJ.
    Cancer Res; 2001 Oct 15; 61(20):7408-12. PubMed ID: 11606371
    [Abstract] [Full Text] [Related]

  • 4. Involvement of MAP-kinase, PI3-kinase and EGF-receptor in the stimulatory effect of Neurotensin on DNA synthesis in PC3 cells.
    Hassan S, Dobner PR, Carraway RE.
    Regul Pept; 2004 Aug 15; 120(1-3):155-66. PubMed ID: 15177934
    [Abstract] [Full Text] [Related]

  • 5. Akt/protein kinase B signaling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells overexpressing Akt.
    Yang L, Dan HC, Sun M, Liu Q, Sun XM, Feldman RI, Hamilton AD, Polokoff M, Nicosia SV, Herlyn M, Sebti SM, Cheng JQ.
    Cancer Res; 2004 Jul 01; 64(13):4394-9. PubMed ID: 15231645
    [Abstract] [Full Text] [Related]

  • 6. Tyrosine kinase-dependent, phosphatidylinositol 3'-kinase, and mitogen-activated protein kinase-independent signaling pathways prevent lung adenocarcinoma cells from anoikis.
    Wei L, Yang Y, Yu Q.
    Cancer Res; 2001 Mar 15; 61(6):2439-44. PubMed ID: 11289112
    [Abstract] [Full Text] [Related]

  • 7. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
    Ou YC, Yang CR, Cheng CL, Raung SL, Hung YY, Chen CJ.
    Eur J Pharmacol; 2007 Jun 01; 563(1-3):49-60. PubMed ID: 17341418
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation.
    Ghosh PM, Malik SN, Bedolla RG, Wang Y, Mikhailova M, Prihoda TJ, Troyer DA, Kreisberg JI.
    Endocr Relat Cancer; 2005 Mar 01; 12(1):119-34. PubMed ID: 15788644
    [Abstract] [Full Text] [Related]

  • 11. TRAIL promotes the survival and proliferation of primary human vascular endothelial cells by activating the Akt and ERK pathways.
    Secchiero P, Gonelli A, Carnevale E, Milani D, Pandolfi A, Zella D, Zauli G.
    Circulation; 2003 May 06; 107(17):2250-6. PubMed ID: 12668516
    [Abstract] [Full Text] [Related]

  • 12. Androgen receptor expression is regulated by the phosphoinositide 3-kinase/Akt pathway in normal and tumoral epithelial cells.
    Manin M, Baron S, Goossens K, Beaudoin C, Jean C, Veyssiere G, Verhoeven G, Morel L.
    Biochem J; 2002 Sep 15; 366(Pt 3):729-36. PubMed ID: 11971763
    [Abstract] [Full Text] [Related]

  • 13. PI3K-FRAP/mTOR pathway is critical for hepatocyte proliferation whereas MEK/ERK supports both proliferation and survival.
    Coutant A, Rescan C, Gilot D, Loyer P, Guguen-Guillouzo C, Baffet G.
    Hepatology; 2002 Nov 15; 36(5):1079-88. PubMed ID: 12395317
    [Abstract] [Full Text] [Related]

  • 14. Phosphatidylinositol 3-kinase (PI-3K)/Akt but not PI-3K/p70 S6 kinase signaling mediates IGF-1-promoted lens epithelial cell survival.
    Chandrasekher G, Sailaja D.
    Invest Ophthalmol Vis Sci; 2004 Oct 15; 45(10):3577-88. PubMed ID: 15452065
    [Abstract] [Full Text] [Related]

  • 15. Immunohistochemical demonstration of phospho-Akt in high Gleason grade prostate cancer.
    Malik SN, Brattain M, Ghosh PM, Troyer DA, Prihoda T, Bedolla R, Kreisberg JI.
    Clin Cancer Res; 2002 Apr 15; 8(4):1168-71. PubMed ID: 11948129
    [Abstract] [Full Text] [Related]

  • 16. The phosphatidylinositol 3-kinase/AKT kinase pathway in multiple myeloma plasma cells: roles in cytokine-dependent survival and proliferative responses.
    Tu Y, Gardner A, Lichtenstein A.
    Cancer Res; 2000 Dec 01; 60(23):6763-70. PubMed ID: 11118064
    [Abstract] [Full Text] [Related]

  • 17. C-Jun N-terminal kinase is required for phorbol ester- and thapsigargin-induced apoptosis in the androgen responsive prostate cancer cell line LNCaP.
    Engedal N, Korkmaz CG, Saatcioglu F.
    Oncogene; 2002 Feb 07; 21(7):1017-27. PubMed ID: 11850819
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antimitogenic and proapoptotic activities of methylseleninic acid in vascular endothelial cells and associated effects on PI3K-AKT, ERK, JNK and p38 MAPK signaling.
    Wang Z, Jiang C, Ganther H, Lü J.
    Cancer Res; 2001 Oct 01; 61(19):7171-8. PubMed ID: 11585751
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.